Industry Trends and Challenges in Life Sciences Supply Chain

The Covid situation has underlined the importance of speedy development and manufacturing of drugs. Most companies prefer to outsource manufacturing, packaging, and distribution activities in the life sciences industry. Manufacturing is done by Contract Manufacturing Organizations (CMO), packaging by Contract Packaging Organizations (CPO), while distribution is the responsibility of Third-Party Logistics (3PL) organizations. A report suggests that with the growing demand for generic medicines and biologics, the business' capital-intensive nature, and the complex manufacturing requirements, many pharmaceutical companies have identified the potential profitability in contracting with CMO for clinical and commercial stage manufacturing. The CMO market is estimated to grow at 4% between 2020 and 2025. The total global biopharmaceutical third-party logistics market size was estimated at USD 86.37 billion in 2018. It is estimated to augment at a CAGR of 4.9% over the forecast time of 2019-2025.

Business Challenges with Planning in Outsourced Life Sciences Supply Chain

The outsourcing business model gives cost efficiency; however, supply chain planning becomes crucial for effectively managing operations. The ownership of inventory and the quality lie with the OEM, although OEM does not have any physical stocks. The goal is to satisfy the demand originating from different parts of the globe and, at the same time, maximize profit. Reduction in inventory and maximizing inventory turns is the key to success. For seamless working of the entire life sciences supply chain starting from vendors, CMO, CPO, 3PL, and distributors, the companies must have complete visibility of the whole supply chain. Central planning function thus becomes imperative for successfully managing the life sciences supply chain operations. Accurate information about quantity, quality, material statuses, shelf life, and expiry of ingredients and intermediates is mandatory for accurate planning. Lead times throughout the supply chain are also vital for meeting the schedules.

Things become complicated when the number of ingredients, intermediates, and SKUs increases. The labeling and packaging requirements are different in different countries. Additionally, increasing the number of CMO, CPO, and 3PL further complicate things.

Solution

Oracle Cloud Supply Chain Planning offers a robust solution to address these challenges. With Oracle Cloud Supply Chain Planning, companies can plan for API procurement from the vendors and plan bulk and intermediate manufacturing at the CMO. Cloud Supply Chain Planning is also preparing for drugs from CMO to CPO for packaging and from CPO to 3PL for logistics and distribution. The solution is driven by maintaining the item master, the bills of material, sourcing rules, and bills of distribution. Sourcing rules and bills of distribution establish the link between CMO and CPO to 3PL. The planning engine automatically calculates supply quantities after considering the inventory quantity, material status, expiration, and shelf life of ingredients, intermediates, and products. Dates for procurement, manufacturing and material movement are calculated based on the vendor lead times, manufacturing lead times, and transit shipment time between CMO, CPO, and 3PL. You can also configure exception rules with the help of which you can quickly pinpoint those items which require your attention. This saves many planners’ time in adjusting the demand and supply.

Oracle Cloud Supply Chain Planning is ERP system agnostic. It is not necessary to have Oracle Fusion as an ERP system. It can seamlessly work with other ERP systems as well.

Benefits of Oracle Supply Chain Planning for the Life Sciences Industry

  • Managing the complex supply chain: The planner gets complete visibility of the supply chain, including CMO, CPO, and 3PL. Instead of planning in silos for these contractors, planning is done to bring synergy to the entire supply chain.
  • Improve on-time order fulfillment: The planning engine suggests ordering dates based on the lead times and transit times, ensuring that order fulfillment dates are honored.
  • Accurate planning: The planner gets the visibility of inventory quantity, material statuses, usability shelf life, and expiry of all the material at CMO, CPO, and 3PL. This ensures that planned quantities are accurate.

Conclusion

Virtual manufacturing is the norm in the life sciences industry. Planning throughout the entire life sciences supply chain planning is a complex job. Oracle Supply Chain Planning addresses these complexities and arrives at a plan by considering inventory, material statuses, expiration, and lead times throughout the supply chain. This helps to optimize the inventory in the life sciences supply chain and maximize profitability.

About the Author

Amogh Dike

Amogh Dike

Senior Manager, Client Services

Amogh is SCM subject matter expert SME in Oracle COE of Jade Global. He is involved in development of industry specific solutions. He manages offshore delivery for enterprise applications for Oracle EBS and SaaS. He has 21 years of experience in Oracle EBS and Fusion applications. He also has 7 years of domain experience in Industrial Manufacturing and Auto Ancillary sector. He has done 15+ implementations in various industries.

How Can We Help You?